Polyrizon Ltd. announced today that it has entered into an agreement with a globally recognized branding and trademark consultancy firm. This firm is known for its work with leading pharmaceutical and medical device companies worldwide.
The collaboration aims to develop a strategic brand name and identity for Polyrizon’s proprietary Capture and Contain™ (C&C) hydrogel technology. This innovative intranasal spray formulation is designed to create a protective biological barrier against allergens and viruses.
This initiative marks a crucial step in Polyrizon's pathway to commercialize its technology and effectively communicate its unique benefits to the market. The engagement will include comprehensive trademark screening and linguistic evaluations across the U.S. and European markets, ensuring optimal brand viability and regulatory compliance.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.